The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence

Keywords

Fatty acid amide hydrolase, Anandamide, Endocannabinoid system, Palmitoylethanolamide, Nicotine

References

• Cannabinoid receptor signaling.A­llyn C. Howlett — 2005
• Presynaptic modulation of transmitter release by nicotinic receptors.Susan Wonnacott, Jane Irons, Catherine Rapier — 1989
• The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine‐induced dopamine elevations in the nucleus accumbens shell in ratsMaría Scherma, Zuzana Justinová, Claudio Zanettini — 2012
• Quantification of brain endocannabinoid levels: methods, interpretations and pitfallsMatthew W. Buczynski, Loren H. Parsons — 2010
• The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intakeIslam Gamaleddin, Mihail Guranda, Steven R. Goldberg — 2011
• Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seekingIslam Gamaleddin, Carrie E. Wertheim, Andy Z. X. Zhu — 2012
• Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amidesBenjamin F. Cravatt, Dan K. Giang, Stephen P. Mayfield — 1996
• The cannabinoid system and its pharmacological manipulation – a review, with emphasis upon the uptake and hydrolysis of anandamideChristopher J. Fowler — 2006
• Nicotinic effects on the firing pattern of midbrain dopamine neurons.Johan Grenhoff, Gary Aston‐Jones, T.H. Svensson — 1986
• The Endogenous Cannabinoid System Modulates Nicotine Reward and DependenceLisa L. Merritt, Billy R. Martin, C. Walters — 2008
• Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-αJin Fu, Silvana Gaetani, Fariba Oveisi — 2003
• Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotineEmmanuel Valjent, Jennifer Mitchell, Marie‐Jo Besson — 2002
• The neurobiology of tobacco addiction.Ian P. Stolerman, Mohammed Shoaib — 1991
• Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in miceGraciela N. Balerio, Ester Aso, Rafaël Maldonado — 2006
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.William A. Devane, Lumir Hanuš, Aviva Breuer — 1992
• Brain Cannabinoid CB2 Receptors Modulate Cocaine’s Actions in MiceZheng‐Xiong Xi, Xiao‐Qing Peng, Xia Li — 2011
• Cannabinoids: A New Group of Agonists of PPARsYan Sun, Andy Bennett — 2007
• Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbensPedro Rada, Kristin Jensen, Bartley G. Hoebel — 2001
• A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivoJason R. Clapper, Federica Vacondio, Alvin R. King — 2009
• Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugsFrancesco E. Pontieri, Gianluigi Tanda, Francesco Orzi — 1996

Cited by

• Role of TRPV1 channels of the dorsal periaqueductal gray in the modulation of nociception and open elevated plus maze-induced antinociception in mice.Àlex Broch — 2015
• Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in miceJosé Trigo, Bernard Le Foll — 2015
• Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortexMartin A. Sticht, Cheryl L. Limebeer, Benjamin R. Rafla — 2015
• Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addictionLeigh V. Panlilio, Zuzana Justinová, Steven R. Goldberg — 2013
• New mechanisms and perspectives in nicotine withdrawalKia J. Jackson, Pretal P. Muldoon, Mariella De Biasi — 2014
• Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors.Murat Öz, Lina Al Kury, Susan Yang Keun-Hang — 2014
• The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in miceBogna M. Ignatowska‐Jankowska, Pretal P. Muldoon, Aron H. Lichtman — 2013
• Inhibition of monoacylglycerol lipase reduces nicotine withdrawalPretal P. Muldoon, Jingchun Chen, JoLynne Harenza — 2015
• Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence.Kenneth A. Perkins, Joshua L. Karelitz, Valerie C. Michael — 2015
• Neuroinflammation as a possible link between cannabinoids and addictionL. C. M. Rodrigues, Pedro H. Gobira, Antônio Carlos de Oliveira — 2013
• Cannabinoid Modulation of Emotion, Memory, and MotivationPatrizia Campolongo, Liana Fattore — 2015
• Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase CJi Jia, Jie Peng, Zhaoju Li — 2016
• Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive‐like behaviorsAmélie Simonnet, Erica Zamberletti, Martine Cador — 2017
• Endocannabinoid Regulation of Nausea and Emesis: The Role of 2-arachidonoylglycerol in LiCl-induced Vomiting in Suncus Murinus and Conditioned Gaping in RatsMartin A. Sticht — 2015
• In vivo Interactions between α7 Nicotinic Acetylcholine Receptor and Nuclear Peroxisome Proliferator-Activated Receptor-α: Implication for Nicotine DependenceAsti Jackson, Deniz Bağdaş, Pretal P. Muldoon — 2017
• Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbensFrancisco Javier Pavón, Antonia Serrano, Nimish Sidhpura — 2017
• Cannabinoid Receptor 1 and Fatty Acid Amide Hydrolase Contribute to Operant Sensation Seeking in MiceAlexander I. Helfand, Christopher M. Olsen, Cecilia J. Hillard — 2017
• Inhibition of Nicotine Dependence by Curcuminoid Is Associated with Reduced Acetylcholinesterase Activity in the Mouse BrainGofarana Wilar, Kusnandar Anggadiredja, Yasuharu Shinoda — 2018
• Neuronal nicotinic acetylcholine receptors mediate ∆9-THC dependence: Mouse and human studiesGiulia Donvito, Pretal P. Muldoon, Kia J. Jackson — 2018
• Novel therapeutic and drug development strategies for tobacco use disorder: endocannabinoid modulationKevin Butler, Bernard Le Foll — 2020

Related papers

• Cannabimimetic Fatty Acid Derivatives: The Anandamide Family and Other 'Endocannabinoids'Dominique Melck, V. Di Marzo, Tiziana Bisogno — 1999
• Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systemsLuciano De Petrocellis, Tiziana Bisogno, Alessia Ligresti — 2002
• Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors.Patricia H. Reggio — 2002
• Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodentsJenny L. Wiley, D. Matthew Walentiny, M. Jerry Wright — 2014
• Metabolism of the endocannabinoids anandamide and 2-arachidonoyl glycerol, a review, with emphasis on the pharmacology of fatty acid amide hydrolase, a possible target for the treatment of neurodegenerative diseases and painChristopher J. Fowler — 2004
• Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamideFrida Loría, Stefania Petrosino, Leyre Mestre — 2008
• Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides?Josée Guindon, Jesse LoVerme, André De Léan — 2006
• Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration—comparison with CB1 receptor blockadeBenoît Forget, Kathleen M. Coen, Bernard Le Foll — 2009
• The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid ReceptorsInés Reynoso-Moreno, Andrea Chicca, Mario Eduardo Flores-Soto — 2018